These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26646461)

  • 1. Modulation by the Noble Gas Helium of Tissue Plasminogen Activator: Effects in a Rat Model of Thromboembolic Stroke.
    Haelewyn B; David HN; Blatteau JE; Vallée N; Meckler C; Risso JJ; Abraini JH
    Crit Care Med; 2016 Jun; 44(6):e383-9. PubMed ID: 26646461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between nitrous oxide and tissue plasminogen activator in a rat model of thromboembolic stroke.
    Haelewyn B; David HN; Colloc'h N; Colomb DG; Risso JJ; Abraini JH
    Anesthesiology; 2011 Nov; 115(5):1044-53. PubMed ID: 21952256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.
    David HN; Haelewyn B; Risso JJ; Colloc'h N; Abraini JH
    J Cereb Blood Flow Metab; 2010 Apr; 30(4):718-28. PubMed ID: 20087367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator.
    David HN; Haelewyn B; Risso JJ; Abraini JH
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):91-5. PubMed ID: 23142817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombolytic action of normobaric oxygen given alone or in combination with recombinant tissue-plasminogen activator in a rat model of thromboembolic stroke.
    David HN; Haelewyn B; Degoulet M; Colomb DG; Risso JJ; Abraini JH
    J Appl Physiol (1985); 2012 Jun; 112(12):2068-76. PubMed ID: 22492935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia.
    David HN; Haelewyn B; Chazalviel L; Lecocq M; Degoulet M; Risso JJ; Abraini JH
    J Cereb Blood Flow Metab; 2009 Jun; 29(6):1159-65. PubMed ID: 19384333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tissue-type plasminogen activator in ischemic stroke.
    Suzuki Y
    J Pharmacol Sci; 2010; 113(3):203-7. PubMed ID: 20595786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
    Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Romanos E; Planas AM; Amaro S; Chamorro A
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
    Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
    Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y; Li Q; Yang T; Hussain M; Shuaib A
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
    J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic treatment of acute ischemic stroke.
    Meschia JF; Miller DA; Brott TG
    Mayo Clin Proc; 2002 Jun; 77(6):542-51. PubMed ID: 12059124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.
    Marder VJ; Blinc A; Gruber T; Tratar G; Sabovic M; Starkman S; Jahan R; Duckwiler G; Vinuela F; Tateshima S; Liebeskind D; Ovbiagele B; Ali L; Kim D; Gonzalez N; Vespa PM; Saver JL
    Stroke; 2011 Aug; 42(8):2222-8. PubMed ID: 21700944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.